BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38059788)

  • 21. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
    Ko EC; Formenti SC
    Int J Radiat Biol; 2019 Jul; 95(7):936-939. PubMed ID: 31120369
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.
    Xu L; Zou C; Zhang S; Chu TSM; Zhang Y; Chen W; Zhao C; Yang L; Xu Z; Dong S; Yu H; Li B; Guan X; Hou Y; Kong FM
    J Hematol Oncol; 2022 Jul; 15(1):87. PubMed ID: 35799264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory effects of radiation: what is next for cancer therapy?
    Kumari A; Simon SS; Moody TD; Garnett-Benson C
    Future Oncol; 2016 Jan; 12(2):239-56. PubMed ID: 26621553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
    D'Andrea MA; Reddy GK
    Am J Clin Oncol; 2020 Mar; 43(3):218-228. PubMed ID: 31842114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Multi-Site Radiation Therapy for Systemic Disease Control.
    Patel RR; Verma V; Barsoumian HB; Ning MS; Chun SG; Tang C; Chang JY; Lee PP; Gandhi S; Balter P; Dunn JD; Chen D; Puebla-Osorio N; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):352-364. PubMed ID: 32798606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences.
    Lumniczky K; Sáfrány G
    Cancer Lett; 2015 Jan; 356(1):114-25. PubMed ID: 23994343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial.
    Donaubauer AJ; Becker I; Weissmann T; Fröhlich BM; Muñoz LE; Gryc T; Denzler M; Ott OJ; Fietkau R; Gaipl US; Frey B
    Front Immunol; 2021; 12():740742. PubMed ID: 34712229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunotherapy and radiotherapy].
    Bockel S; Antoni D; Deutsch É; Mornex F
    Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8
    Yoon YN; Lee E; Kwon YJ; Gim JA; Kim TJ; Kim JS
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer.
    Zhang X; Cai X; Yan C
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18253-18270. PubMed ID: 37985502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
    Herrera FG; Ronet C; Ochoa de Olza M; Barras D; Crespo I; Andreatta M; Corria-Osorio J; Spill A; Benedetti F; Genolet R; Orcurto A; Imbimbo M; Ghisoni E; Navarro Rodrigo B; Berthold DR; Sarivalasis A; Zaman K; Duran R; Dromain C; Prior J; Schaefer N; Bourhis J; Dimopoulou G; Tsourti Z; Messemaker M; Smith T; Warren SE; Foukas P; Rusakiewicz S; Pittet MJ; Zimmermann S; Sempoux C; Dafni U; Harari A; Kandalaft LE; Carmona SJ; Dangaj Laniti D; Irving M; Coukos G
    Cancer Discov; 2022 Jan; 12(1):108-133. PubMed ID: 34479871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of radiotherapy and immune checkpoint inhibitors.
    Pilones KA; Vanpouille-Box C; Demaria S
    Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mutual relationship between the host immune system and radiotherapy: stimulating the action of immune cells by irradiation.
    Watanabe T; Sato GE; Yoshimura M; Suzuki M; Mizowaki T
    Int J Clin Oncol; 2023 Feb; 28(2):201-208. PubMed ID: 35556190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Abscopal effect: Myth or reality?].
    Mirjolet C; Truc G
    Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy and radiation.
    Hiniker SM; Knox SJ
    Semin Oncol; 2014 Dec; 41(6):702-13. PubMed ID: 25499631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma.
    Barsoumian HB; Ramapriyan R; Younes AI; Caetano MS; Menon H; Comeaux NI; Cushman TR; Schoenhals JE; Cadena AP; Reilly TP; Chen D; Masrorpour F; Li A; Hong DS; Diab A; Nguyen QN; Glitza I; Ferrarotto R; Chun SG; Cortez MA; Welsh J
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy.
    Guan H; Zhou Z; Hou X; Zhang F; Zhao J; Hu K
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):35-50. PubMed ID: 35538049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.